Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.080 | 2 | 25234839 | intron variant | T/A;C | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.925 | 0.080 | 2 | 25234839 | intron variant | T/A;C | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.882 | 0.080 | 2 | 25262866 | intron variant | C/T | snv | 0.45 |
|
Mental Disorders | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.882 | 0.080 | 2 | 25262866 | intron variant | C/T | snv | 0.45 |
|
Mental Disorders | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.882 | 0.080 | 2 | 25262866 | intron variant | C/T | snv | 0.45 |
|
Nervous System Diseases; Mental Disorders | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.882 | 0.080 | 2 | 25262866 | intron variant | C/T | snv | 0.45 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.882 | 0.160 | 2 | 25231099 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2018 | 2018 | ||||||||
|
0.882 | 0.160 | 2 | 25231099 | 3 prime UTR variant | C/G;T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.827 | 0.120 | 2 | 25269598 | intron variant | A/G | snv | 0.31 |
|
0.010 | < 0.001 | 1 | 2019 | 2019 | ||||||||
|
0.827 | 0.120 | 2 | 25269598 | intron variant | A/G | snv | 0.31 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | < 0.001 | 1 | 2019 | 2019 | |||||||
|
0.827 | 0.120 | 2 | 25269598 | intron variant | A/G | snv | 0.31 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.827 | 0.120 | 2 | 25269598 | intron variant | A/G | snv | 0.31 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.827 | 0.120 | 2 | 25269598 | intron variant | A/G | snv | 0.31 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.827 | 0.120 | 2 | 25269598 | intron variant | A/G | snv | 0.31 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.120 | 2 | 25243904 | missense variant | C/T | snv |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2017 | 2017 | ||||||||
|
0.925 | 0.120 | 2 | 25243904 | missense variant | C/T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | < 0.001 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 2 | 25246661 | missense variant | C/A;T | snv |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.776 | 0.240 | 2 | 25234373 | missense variant | C/A;G;T | snv | 4.0E-06; 4.0E-06; 2.2E-04 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.776 | 0.240 | 2 | 25234373 | missense variant | C/A;G;T | snv | 4.0E-06; 4.0E-06; 2.2E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.790 | 0.320 | 2 | 25343038 | upstream gene variant | A/G;T | snv |
|
Infections | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.790 | 0.320 | 2 | 25343038 | upstream gene variant | A/G;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.790 | 0.320 | 2 | 25343038 | upstream gene variant | A/G;T | snv |
|
Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.790 | 0.320 | 2 | 25343038 | upstream gene variant | A/G;T | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.790 | 0.320 | 2 | 25343038 | upstream gene variant | A/G;T | snv |
|
Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.790 | 0.320 | 2 | 25343038 | upstream gene variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 |